Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of JNJ-63623872 plus oseltamivir in hospitalized adults and elderly patients with influenza A
2015-003002-17Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A infection comparing JNJ-63623872 + oseltamivir with Placebo + oseltamivir (2 arms). Primary endpoint: Trough plasma concentration of JNJ-63623872. Started Sep 2015; status: completed.
02
Drugs
pimodiviroseltamivir
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2015-003002-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003002-17.